1. Home
  2. TCRX vs MAMO Comparison

TCRX vs MAMO Comparison

Compare TCRX & MAMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCRX
  • MAMO
  • Stock Information
  • Founded
  • TCRX 2018
  • MAMO 2008
  • Country
  • TCRX United States
  • MAMO United States
  • Employees
  • TCRX N/A
  • MAMO N/A
  • Industry
  • TCRX Biotechnology: Pharmaceutical Preparations
  • MAMO
  • Sector
  • TCRX Health Care
  • MAMO
  • Exchange
  • TCRX Nasdaq
  • MAMO NYSE
  • Market Cap
  • TCRX 90.5M
  • MAMO 98.1M
  • IPO Year
  • TCRX 2021
  • MAMO 2024
  • Fundamental
  • Price
  • TCRX $1.38
  • MAMO $2.28
  • Analyst Decision
  • TCRX Strong Buy
  • MAMO
  • Analyst Count
  • TCRX 7
  • MAMO 0
  • Target Price
  • TCRX $9.86
  • MAMO N/A
  • AVG Volume (30 Days)
  • TCRX 396.8K
  • MAMO 15.1K
  • Earning Date
  • TCRX 05-06-2025
  • MAMO 05-13-2025
  • Dividend Yield
  • TCRX N/A
  • MAMO N/A
  • EPS Growth
  • TCRX N/A
  • MAMO N/A
  • EPS
  • TCRX N/A
  • MAMO 0.08
  • Revenue
  • TCRX $4,421,000.00
  • MAMO $111,209,142.00
  • Revenue This Year
  • TCRX $47.30
  • MAMO N/A
  • Revenue Next Year
  • TCRX $74.30
  • MAMO N/A
  • P/E Ratio
  • TCRX N/A
  • MAMO $29.64
  • Revenue Growth
  • TCRX N/A
  • MAMO N/A
  • 52 Week Low
  • TCRX $1.02
  • MAMO $2.16
  • 52 Week High
  • TCRX $9.69
  • MAMO $4.66
  • Technical
  • Relative Strength Index (RSI)
  • TCRX 42.86
  • MAMO N/A
  • Support Level
  • TCRX $1.32
  • MAMO N/A
  • Resistance Level
  • TCRX $1.65
  • MAMO N/A
  • Average True Range (ATR)
  • TCRX 0.13
  • MAMO 0.00
  • MACD
  • TCRX -0.01
  • MAMO 0.00
  • Stochastic Oscillator
  • TCRX 14.63
  • MAMO 0.00

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

About MAMO MASSIMO GROUP

Massimo Group is engaged in the mid-tier band the (Mid-Tier Band) of the Powersports Vehicles and Boats Industry. It manufacture, import and distribute a diversified portfolio of products divided into two main lines: a motor sports brand consisting of utility terrain vehicles (UTVs), all-terrain vehicles (ATVs), motorcycles, scooters, golf carts, and a juvenile line from go karts to balance bikes; and a motor boat line consisting of pontoon and tritoon boats (Pontoon Boats).

Share on Social Networks: